Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Flamen

Showing results (31-40 of 124) with videos related to

Pageof 13
Sort By:
EJNMMI Physics|January 28, 2017
Accuracy and precision assessment for activity quantification in individualized dosimetry of <sup>177</sup>Lu-DOTATATE therapyGwennaëlle Marin, Bruno Vanderlinden, Ioannis Karfis, et al.
Diagnostics (Basel, Switzerland)|April 14, 2026
Renal Peripelvic Extramedullary Haematopoiesis in Myelofibrosis: A Rare Imaging Pitfall Assessed by Multimodality Nuclear ImagingRedouane Soussi, Ayoub Jaafari, Anas Chbabou, et al.
Anti-Cancer Drugs|November 1, 2006
Imatinib mesylate in a patient with metastatic disease originating from a dermatofibrosarcoma protuberans of the scalpBernd Kasper, Dominique Lossignol, Thierry Gil, et al.
Hellenic Journal of Nuclear Medicine|July 12, 2017
Unusual diffuse liver <sup>18</sup>F-FDG uptake in melanoma patient treated by ipilimumabRaoul Muteganya, Ioannis Karfis, Carlos Artigas, et al.
Journal of Magnetic Resonance Imaging : JMRI|April 17, 2018
Total choline quantification measured by 1H MR spectroscopy as early predictor of response after neoadjuvant treatment for locally advanced breast cancer: The impact of immunohistochemical statusStylianos Drisis, Patrick Flamen, Michael Ignatiadis, et al.
EJNMMI Reports|September 17, 2024
Phosphaturic mesenchymal tumor demonstrated by <sup>68</sup>Ga-DOTATATE PET/CT in a patient: a case reportYounes Abadi, Magdalena Mileva, Marc-André Léger, et al.
European Journal of Hybrid Imaging|April 19, 2022
Suspicious cold thyroid nodule with intense focal 68Ga-DOTATATE uptake: a case reportRingo Manta, Wendy Delbart, Ivan Duran Derijckere, et al.
Annals of Nuclear Medicine|October 7, 2019
Evaluation of PSMA expression changes on PET/CT before and after initiation of novel antiandrogen drugs (enzalutamide or abiraterone) in metastatic castration-resistant prostate cancer patientsNicolas Plouznikoff, Carlos Artigas, Spyridon Sideris, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 2018
Validation of Metabolically Active Tumor Volume and Total Lesion Glycolysis as 18F-FDG PET/CT–derived Prognostic Biomarkers in Chemorefractory Metastatic Colorectal CancerErwin Woff, Alain Hendlisz, Lieveke Ameye, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 10, 2019
Combining <sup>18</sup>F-FDG PET/CT-Based Metabolically Active Tumor Volume and Circulating Cell-Free DNA Significantly Improves Outcome Prediction in Chemorefractory Metastatic Colorectal CancerErwin Woff, Pashalina Kehagias, Caroline Vandeputte, et al.
Pageof 13

Showing results (31-40 of 124) with videos related to

Sort By:
Pageof 13
EJNMMI Physics|January 28, 2017
Accuracy and precision assessment for activity quantification in individualized dosimetry of <sup>177</sup>Lu-DOTATATE therapyGwennaëlle Marin, Bruno Vanderlinden, Ioannis Karfis, et al.
Diagnostics (Basel, Switzerland)|April 14, 2026
Renal Peripelvic Extramedullary Haematopoiesis in Myelofibrosis: A Rare Imaging Pitfall Assessed by Multimodality Nuclear ImagingRedouane Soussi, Ayoub Jaafari, Anas Chbabou, et al.
Anti-Cancer Drugs|November 1, 2006
Imatinib mesylate in a patient with metastatic disease originating from a dermatofibrosarcoma protuberans of the scalpBernd Kasper, Dominique Lossignol, Thierry Gil, et al.
Hellenic Journal of Nuclear Medicine|July 12, 2017
Unusual diffuse liver <sup>18</sup>F-FDG uptake in melanoma patient treated by ipilimumabRaoul Muteganya, Ioannis Karfis, Carlos Artigas, et al.
Journal of Magnetic Resonance Imaging : JMRI|April 17, 2018
Total choline quantification measured by 1H MR spectroscopy as early predictor of response after neoadjuvant treatment for locally advanced breast cancer: The impact of immunohistochemical statusStylianos Drisis, Patrick Flamen, Michael Ignatiadis, et al.
EJNMMI Reports|September 17, 2024
Phosphaturic mesenchymal tumor demonstrated by <sup>68</sup>Ga-DOTATATE PET/CT in a patient: a case reportYounes Abadi, Magdalena Mileva, Marc-André Léger, et al.
European Journal of Hybrid Imaging|April 19, 2022
Suspicious cold thyroid nodule with intense focal 68Ga-DOTATATE uptake: a case reportRingo Manta, Wendy Delbart, Ivan Duran Derijckere, et al.
Annals of Nuclear Medicine|October 7, 2019
Evaluation of PSMA expression changes on PET/CT before and after initiation of novel antiandrogen drugs (enzalutamide or abiraterone) in metastatic castration-resistant prostate cancer patientsNicolas Plouznikoff, Carlos Artigas, Spyridon Sideris, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 2018
Validation of Metabolically Active Tumor Volume and Total Lesion Glycolysis as 18F-FDG PET/CT–derived Prognostic Biomarkers in Chemorefractory Metastatic Colorectal CancerErwin Woff, Alain Hendlisz, Lieveke Ameye, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 10, 2019
Combining <sup>18</sup>F-FDG PET/CT-Based Metabolically Active Tumor Volume and Circulating Cell-Free DNA Significantly Improves Outcome Prediction in Chemorefractory Metastatic Colorectal CancerErwin Woff, Pashalina Kehagias, Caroline Vandeputte, et al.
Pageof 13